Maag-, darm- en leverziekten

Over the past decade, great strides have been made in both the diagnostics and treatment of gastrointestinal and liver diseases. Chronic hepatitis C has become an easy-to-treat disease, several new treatment options for inflammatory bowel disease have been introduced, which has led to higher remission rates, and a bowel screening programme has also been introduced in the Netherlands. Although some expected developments did not materialise, new developments are fast approaching in the coming decade. In this article we describe the pearls and pitfalls of the treatment of gastrointestinal and liver disease in second decade of the 21st century, and finally what we might expect in the third decade.

Conflict of interest and financial support: potential conflicts of interest have been reported for this article. ICMJE forms provided by the authors are available online along with the full text of this article.